Pharma Journalist - Page 698 of 831 -

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ, to the U.S. FDA

Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711

Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies

Teva announces Launch of a Generic Version of Syprine in the United States

LakePharma announces expansion and new MicroBiomanufacturing Center in Hopkinton, MA

Therapeutic Application of Botulinum Neurotoxin in Pain: A pre-clinical approach

Seventure Partners joins the panel at Microbiome Invest 2018

Design Principles for Maximising the Drug Delivery Efficiency & Therapeutic Index of ADCs, Presented by Seattle Genetics, at SMi’s ADC Conference

ProBioGen and TEVA sign license agreement on HuALN Technology

Sanofi announces new safety data for investigational avalglucosidase alfa in patients with Pompe disease

ERT Expands Respiratory Solutions to Support New Endpoints

Bavarian Nordic announces positive results of Pivotal Phase 3 Study of IMVAMUNE smallpox vaccine

Circassia receives contract from Vizient for NIOX VERO Asthma Management Products